Medexus Pharmaceutical (MEDXF)
Institutional ownership reported to the SEC as of Q2 2023, across 10 quarters.
1
Reporting holders
$14.1K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Bard Financial Services, Inc. | $14.1K | 10,000 | 0.00% | 3q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2023 | 1 | $14.1K | 10,000 | 0 | 0 | 0 | 0.0% |
| Q1 2023 | 1 | $11.8K | 10,000 | 0 | 0 | 0 | 0.0% |
| Q4 2022 | 1 | $15 | 10,000 | 1 | 0 | 0 | 0.0% |
| Q1 2022 | 1 | $88.0K | 35,000 | 0 | 1 | 0 | 0.0% |
| Q4 2021 | 1 | $50.0K | 25,000 | 0 | 0 | 1 | 0.0% |
| Q3 2021 | 1 | $66.0K | 28,000 | 0 | 1 | 0 | 0.0% |
| Q2 2021 | 1 | $118.0K | 20,000 | 0 | 1 | 0 | 0.0% |
| Q1 2021 | 1 | $88.0K | 14,000 | 0 | 1 | 0 | 0.0% |
| Q4 2020 | 1 | $54.0K | 10,000 | 0 | 0 | 0 | 0.0% |
| Q3 2020 | 1 | $29.0K | 10,000 | 1 | 0 | 0 | 0.0% |